Growth Metrics

Ultragenyx Pharmaceutical (RARE) EBT Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 12.59%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -148.28%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -313.33%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 71.54%
7 Evaxion A 62.56 Bn 62.54 Bn - -79.57%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -8.15%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 9,460.35%
10 Ultragenyx Pharmaceutical 2.29 Bn 1.89 Bn 106.00 Mn -22.67%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -22.67%
Dec 31, 2025 -129.68%
Sep 30, 2025 -34.78%
Jun 30, 2025 12.80%
Mar 31, 2025 11.88%
Dec 31, 2024 437.59%
Sep 30, 2024 16.22%
Jun 30, 2024 17.82%
Mar 31, 2024 -4.13%
Dec 31, 2023 16.87%
Sep 30, 2023 33.42%
Jun 30, 2023 -0.78%
Mar 31, 2023 -7.72%
Dec 31, 2022 -22.85%
Sep 30, 2022 -227.98%
Jun 30, 2022 -29.43%
Mar 31, 2022 -11.79%
Dec 31, 2021 -421.16%
Sep 30, 2021 -6.25%
Jun 30, 2021 -574.02%
Mar 31, 2021 -14.46%
Dec 31, 2020 73.76%
Sep 30, 2020 39.19%
Jun 30, 2020 126.00%
Mar 31, 2020 -22.87%
Dec 31, 2019 -4.04%
Sep 30, 2019 -29.45%
Jun 30, 2019 -88.04%
Mar 31, 2019 -418.70%
Dec 31, 2018 10.46%
Sep 30, 2018 -9.90%
Jun 30, 2018 27.79%
Mar 31, 2018 144.36%
Dec 31, 2017 -37.47%
Sep 30, 2017 -22.06%
Jun 30, 2017 -28.03%
Mar 31, 2017 -29.74%
Dec 31, 2016 -28.99%
Sep 30, 2016 -65.31%
Jun 30, 2016 -91.75%
Mar 31, 2016 -147.95%
Dec 31, 2015 -229.83%
Sep 30, 2015 -150.66%
Jun 30, 2015 -118.52%
Mar 31, 2015 -55.75%
Dec 31, 2014 -76.93%
Sep 30, 2014 -103.61%
Jun 30, 2014 -57.00%
Mar 31, 2014 -101.60%